The Scientific Advisory Board (SAB), represented by Drs. Steve Abman (Univ. of Colorado), Nicholas Morrell (Univ. of Cambridge), Dean Sheppard (UCSF) and Wolfgang Kuebler (Univ. of Toronto) convened on May 13th, 2016 at the Bayer HeathCare U.S. Innovation Center in San Francisco, CA, for the fifth annual review of the Ludwig-Boltzmann Institute for Lung Vascular Research. The review was conducted according to the Rules and Regulations of the Ludwig-Boltzmann Gesellschaft (LBG), represented by Dr. Peter Mayrhofer.
The development and achievements of the LBI over the past 3 years were presented by the Institute´s Director, Dr. Andrea Olschewski. At the end, the SAB members convened to discuss their evaluation and reach consensus.